Knight Therapeutics Inc.
GUD.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.12M | 1.52M | 7.67M | 62.30K | -1.42M |
| Total Depreciation and Amortization | 8.77M | 8.07M | 9.32M | 9.82M | 9.62M |
| Total Amortization of Deferred Charges | -- | -- | 662.90K | -- | -- |
| Total Other Non-Cash Items | 5.60M | 995.00K | -7.88M | 1.86M | -278.40K |
| Change in Net Operating Assets | 9.39M | -8.03M | -8.72M | -8.06M | -8.72M |
| Cash from Operations | 14.64M | 2.56M | 1.05M | 3.68M | -793.70K |
| Capital Expenditure | -448.10K | -259.90K | -400.00K | -274.20K | -502.80K |
| Sale of Property, Plant, and Equipment | -- | 20.90K | 71.40K | -- | 2.20K |
| Cash Acquisitions | -77.25M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.49M | 22.62M | 13.22M | 8.73M | 9.09M |
| Cash from Investing | -73.21M | 22.38M | 12.89M | 8.45M | 8.59M |
| Total Debt Issued | 109.39M | 1.81M | 543.00K | 1.64M | 747.00K |
| Total Debt Repaid | -55.88M | -2.71M | -7.97M | -3.04M | -7.91M |
| Issuance of Common Stock | 363.00K | 114.00K | 140.00K | 448.00K | 340.00K |
| Repurchase of Common Stock | -6.00K | -3.35M | -5.15M | -2.47M | -1.24M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.06M | -569.00K | -2.92M | -503.00K | -3.30M |
| Cash from Financing | 36.73M | -3.27M | -10.97M | -2.88M | -8.30M |
| Foreign Exchange rate Adjustments | -2.97M | 663.30K | 1.56M | 243.40K | -974.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -24.82M | 22.33M | 4.54M | 9.49M | -1.48M |